Literature DB >> 10951246

High incidence and regression rates of solar keratoses in a queensland community.

C Frost1, G Williams, A Green.   

Abstract

The presence of solar keratoses on the skin is one of the major risk factors for basal cell and squamous cell carcinomas, which constitute a growing public health problem in today's white populations. In spite of this, little is known of the natural history of solar keratoses. We conducted follow-up studies to monitor the incidence, regression, and recurrence rates of solar keratoses in a random sample (N = 96) of the Nambour community in Queensland. At baseline, 43 participants (46%) were diagnosed with at least one solar keratosis [26 men (55%), 17 women (37%)] with a total count of 494 prevalent solar keratoses. The distribution of lesions per person was highly skewed, with 11 individuals (12%) having 65% of the total number of solar keratoses. During 12 mo of follow-up, 614 incident solar keratoses were diagnosed (549 in men and 65 in women); 526 solar keratoses regressed and 53 prevalent solar keratoses recurred, giving a net 45% increase in solar keratosis numbers in men (from 354 to 512 solar keratoses) and a net 44% reduction in women (from 114 to 64). Regression rates were higher in prevalent (74%) than incident (29%) solar keratoses. Solar keratosis prevalence increased with age in both sexes, and individuals with solar keratoses at baseline were over seven times more likely to develop additional solar keratoses in the next 12 mo than those without prevalent solar keratoses at baseline. These results show that the natural history of solar keratoses in the community is one of high turnover and that a small percentage of susceptible individuals carry the major burden of solar keratoses in the community.

Entities:  

Mesh:

Year:  2000        PMID: 10951246     DOI: 10.1046/j.1523-1747.2000.00048.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

1.  UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.

Authors:  Valerie Anne Trabosh; Ahmad Daher; Kyle A Divito; Karishma Amin; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Exp Dermatol       Date:  2008-10-23       Impact factor: 3.960

2.  Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.

Authors:  James Q Del Rosso; Leon Kircik; Gary Goldenberg; Berman Brian
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

3.  The clinical course of actinic keratosis correlates with underlying molecular mechanisms.

Authors:  A Bakshi; R Shafi; J Nelson; W C Cantrell; S Subhadarshani; A Andea; M Athar; C A Elmets
Journal:  Br J Dermatol       Date:  2019-09-11       Impact factor: 9.302

Review 4.  Interventions for actinic keratoses.

Authors:  Aditya K Gupta; Maryse Paquet; Elmer Villanueva; William Brintnell
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

5.  Variation in the Cost of Managing Actinic Keratosis.

Authors:  Joslyn S Kirby; Tanner Gregory; Guodong Liu; Douglas L Leslie; Jeffrey J Miller
Journal:  JAMA Dermatol       Date:  2017-04-01       Impact factor: 10.282

6.  Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.

Authors:  Katherine Berry; Melissa Butt; Joslyn S Kirby
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

Review 7.  Health economic evaluation of non-melanoma skin cancer and actinic keratosis.

Authors:  Mitchell K Higashi; David L Veenstra; Paul C Langley
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  Pharmacoeconomic considerations in treating actinic keratosis.

Authors:  Marjorie V Neidecker; Mary Lynn Davis-Ajami; Rajesh Balkrishnan; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 9.  [Skin tumours of the facial area].

Authors:  M Braun-Falco
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

Review 10.  How to treat actinic keratosis? An update.

Authors:  Claudia Costa; Massimiliano Scalvenzi; Fabio Ayala; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  J Dermatol Case Rep       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.